Article Details
Retrieved on: 2025-09-17 12:19:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... synthetic biology and personalized medicine. Bio-Techne (NASDAQ: TECH) reported Q2 2025 revenues of $317 million, up 3.5% year-over-year (YoY) ...
Article found on: www.ainvest.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here